Skip to content

Clinical trials

Phase 1/2 Tobacco Use Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Tobacco Use Disorder Phase: Phase 1/2 Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20042
20073
20081
20102
20114
20121
20132
20141
20163
20193
20213
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Terminated3
Withdrawn3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Yale University5
University of Vermont3
Boston Children's Hospital2
Brown University2
National Institute on Drug Abuse (NIDA)2
Consumer Wellness Solutions1
Duke University1
Embera NeuroTherapeutics, Inc.1
Georgetown University1
Heinrich-Heine University, Duesseldorf1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Tobacco Use Disorder27
Alcoholism3
Body Weight2
Substance-Related Disorders2
Acquired Immunodeficiency Syndrome1
Bipolar Disorder1
Heroin Dependence1
Marijuana Abuse1
Obesity1
Schizophrenia1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.